Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial
Robert D. McBane, Charles L. Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen M. Sanfilippo, Jane Jijun Liu, David García, James M. Heun, Krishna Gundabolu, Adedayo A. Onitilo, Usha Perepu, Monic R. Drescher, Stanislav Henkin, Damon E. Houghton, Aneel A. Ashrani, Henny H. Billett, Shaylene McCue, Minji K. Lee, Jennifer Le‐Rademacher, Waldemar E. Wysokiński
Topics & Concepts
ApixabanMedicineVenous thromboembolismSecondary preventionCancerInternal medicineOncologyRivaroxabanThrombosisWarfarinAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesCardiac tumors and thrombi